Skip to content

Public FDA record

Z-2308-2012: Status Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852

Recall record Z-2308-2012 for Princeton Biomeditech Corp. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2308-2012
Company in FDA record
Princeton Biomeditech Corp
FDA classification date
Aug 31, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

There have been reports of dual positive (Flu A + Flu B positive) results being encountered.

Source facts

Action
OraSure Technologies, Inc. sent an "IMPORTANT NOTICE FOR ORASURE QUICKFLU RAPID FLU A + B TEST" letter dated March 13, 2012 to all affected customers. The letter identifies the product, problem, and actions to be taken by the customers. Contact the firm at 610-882-1820 for questions concerning this recall.
Initiated
2012-03-09
Root cause
Nonconforming Material/Component
Terminated
2014-10-14
Distribution
Nationwide Distribution-including the states of NJ, NY, and PA.
Recall number
Z-2308-2012
Recall status
Terminated
CDRH record ID
110880
FDA classified
2012-08-31
Recall event number
62537

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗